The company manufactures and repairs power and distribution transformers for utilities and industrial clients, while its subsidiary produces galvanized iron wires and strips for the infrastructure and construction sectors.
The company operates in a highly competitive, tender-driven industry with low barriers to entry, evidenced by chronically low net margins (2.4%) and ROCE (7.7%) that fail to exceed the cost of capital.
Capital is primarily reinvested into low-return manufacturing assets and a wire subsidiary that has struggled with profitability; the company has not paid a dividend since 2011 despite maintaining a low debt profile.
The investment collapsed as the company remained trapped in a low-return cycle, where capital was continuously incinerated in low-margin manufacturing and a struggling wire subsidiary. Despite modest revenue growth, the negative EPS CAGR persisted as the company failed to overcome its cost of capital, eventually leading to a liquidity crunch when execution delays—already observed in FY26—became the norm rather than the exception. The lack of dividends for nearly two decades and questionable related-party loans signaled a total disregard for minority shareholders, leaving investors holding a depreciating asset that the market finally re-rated to its dismal book value.
RichFakir rates RTS Power Corporation Ltd's business quality as poor — 22/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, RTS Power Corporation Ltd is trading about 84% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on RTS Power Corporation Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of RTS Power Corporation Ltd's fair value is about ₹58 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →